Literature DB >> 3891654

Antinociceptive models displaying peripheral opioid activity.

T W Smith, R L Follenfant, S H Ferreira.   

Abstract

A writhing syndrome was induced in mice by intraperitoneal administration of carbacyclin (1-100 micrograms/kg), a potent stable analogue of prostacyclin. A quaternary opiate agonist and antagonist, N-methyl morphine and N-methyl nalorphine respectively, exhibited potent antinociceptive properties on subcutaneous administration in this model. Naloxone and naltrexone also displayed weak antinociceptive activity in carbacyclin-induced writhing. Given subcutaneously, N-methyl morphine, but not N-methyl nalorphine or naloxone, inhibited carrageenan-induced hyperalgesia in the rat paw. Thus, demonstration of the peripheral antinociceptive effects of quaternary morphine or nalorphine depends upon the experimental model used, in which small variations may affect the ability to exhibit such effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891654

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  10 in total

1.  Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei inhibit inflammatory pain in mice by targeting serotoninergic receptors.

Authors:  Rafaela Quintanilha Abrahão; Adriano Cardoso Franciosi; Douglas Andrade; Luiz Juliano; Maria Aparecida Juliano; Renata Giorgi; Camila Squarzoni Dale
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

2.  Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions.

Authors:  R L Follenfant; G W Hardy; L A Lowe; C Schneider; T W Smith
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

3.  The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.

Authors:  N S Doherty; T H Beaver; K Y Chan; R J Dinerstein; K A Diekema
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

4.  The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in mice.

Authors:  N S Doherty; T H Beaver; K Y Chan; J E Coutant; G L Westrich
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

5.  Evaluation of opioid-induced antinociceptive effects in anaesthetized and conscious animals.

Authors:  S J Clark; R L Follenfant; T W Smith
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

6.  A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

Authors:  A Barber; G D Bartoszyk; H M Bender; R Gottschlich; H E Greiner; J Harting; F Mauler; K O Minck; R D Murray; M Simon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance.

Authors:  S H Ferreira; B B Lorenzetti; M Devissaguet; D Lesieur; Y Tsouderos
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  The Study of Analgesic Effects of Leonurus cardiaca L. in Mice by Formalin, Tail Flick and Hot Plate Tests.

Authors:  Masoume Rezaee-Asl; Mandana Sabour; Vahid Nikoui; Sattar Ostadhadi; Azam Bakhtiarian
Journal:  Int Sch Res Notices       Date:  2014-09-01

9.  Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity.

Authors:  Yong Sean Goh; Thiruventhan Karunakaran; Vikneswaran Murugaiyah; Rameshkumar Santhanam; Mohamad Hafizi Abu Bakar; Surash Ramanathan
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

10.  Antinociceptive and Anti-Inflammatory Activities of the Ethanolic Extract from Synadenium umbellatum Pax. (Euphorbiaceae) Leaves and Its Fractions.

Authors:  Rodrigo Borges; Marcus Vinícius Mariano Nascimento; Adryano Augustto Valladão de Carvalho; Marize Campos Valadares; José Realino de Paula; Elson Alves Costa; Luiz Carlos da Cunha
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-21       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.